BioSim Partner News

05

Márta 2024

0

Samsung Bioepis joins BioSim as a partner

28

November 2023

0

The ninth edition of the "Expert Diploma in Biosimilars" ends

November 28 2023 Members news Biosim

06

July 2023

0

Companies associated with BioSim, among the best qualified in the Profarma Plan

Jul 06 2023 Members news Biosim

18

Apr 2023

0

Amgen joins Biosim to promote initiatives on biosimilars

Apr 18 2023 Members news Biosim

09

Apr 2023

0

mAbxience expands the facilities of the León Technology Park

Apr 09 2023 Members news Biosim

17

November 2022

0

Teva reaffirms its commitment to biosimilar medicines after joining BioSim

November 17 2022 Members news Biosim

16

November 2022

0

30 specialists obtain the "Biosimilar Expert Diploma" from Kern Pharma

November 16 2022 Members news Biosim

18

Jan 2022

0

Organon joins BioSim in a clear commitment to biosimilar medicines

Jan 18 2022 Members news Biosim

03

December 2021

0

Present in the area of biosimilars, Fina Lladós explains the challenges and strengths of Amgen

03 2021 December Members news Biosim

23

November 2021

0

Interview with Miklós Auerbach, CEO of Gedeon Richter

November 23 2021 Members news Biosim

22

November 2021

0

An initiative of Kern Pharma. Closed the 7th edition of the Own Title of University Expert in Biosimilars

November 22 2021 Members news Biosim

23

Deireadh Fómhair 2021

0

Montse Planas: "The health system has to invent measures that promote the use of biosimilars"

October 23 2021 Members news Biosim

15

Deireadh Fómhair 2021

0

"Spain has the opportunity to be a benchmark for Europe in biosimilars"

October 15 2021 Members news Biosim

11

Meitheamh 2021

0

Kern Pharma wins SABER Awards EMEA for its Biosimilar Hunters app

11 June 2021 Members news Biosim

09

Apr 2021

0

View of the Minister of Science and Innovation, Pedro Duque, at the mAbxience biosimilar manufacturing plant.

Apr 09 2021 Members news Biosim

13

Jan 2021

0

Biosimilars: for value-based healthcare

Jan 13 2021 Members news Biosim

10

Jan 2021

0

Insud Pharma has 3 plants in the province of León that generate more than 600 jobs

Jan 10 2021 Members news Biosim

05

Jan 2021

0

Fresenius Kabi highly values its entry into the field of biosimilars, on the first anniversary of the launch of Idacio

Jan 05 2021 Members news Biosim

07

Sep 2020

0

Kern Pharma donates 200 computers to support the training of young people during the 2020/2021 academic year

07 September 2020 Members news Biosim

21

May 2020

0

Fresenius Kabi donates more than 110.000 masks and gloves during the coronavirus crisis to help healthcare professionals in Spain

21 May 2020 Members news Biosim

15

Apr 2020

0

Amgen and Adaptative Biotechnologies to develop a treatment for the coronavirus

Apr 15 2020 Members news Biosim

13

Apr 2020

0

Novartis plans to publish hydroxychloroquine data this month

Apr 13 2020 Members news Biosim

13

Apr 2020

0

Pfizer advances with its projects to contribute to the treatment and prevention of Covid-19

Apr 13 2020 Members news Biosim

10

Apr 2020

0

Sanofi includes Spain among the countries that will receive its medicine against the coronavirus

Apr 10 2020 Members news Biosim

06

Apr 2020

0

Coronavirus.- STADA donates 50.000 masks and hygiene products to fight Covid-19

Apr 06 2020 Members news Biosim

02

Apr 2020

0

Novartis donates critical material for hospitals worth one million euros to the health air corridor

Apr 02 2020 Members news Biosim

26

Márta 2020

0

Rovi announces the donation of one million masks to Health

March 26 2020 Members news Biosim

21

February 2020

0

mAbxience inaugurates a new biosimilar monoclonal antibody plant in Argentina

Feb 21 2020 Members news Biosim

10

Deireadh Fómhair 2019

0

Kern Pharma launches “Biosimilar Hunters”, the first app on biosimilars

October 10 2019 Members news Biosim

News about our members

Samsung Bioepis joins BioSim as a partner

The ninth edition of the "Expert Diploma in Biosimilars" ends

Companies associated with BioSim, among the best qualified in the Profarma Plan

Amgen joins Biosim to promote initiatives on biosimilars

mAbxience expands the facilities of the León Technology Park

Teva reaffirms its commitment to biosimilar medicines after joining BioSim

30 specialists obtain the "Biosimilar Expert Diploma" from Kern Pharma

Organon joins BioSim in a clear commitment to biosimilar medicines

Present in the area of biosimilars, Fina Lladós explains the challenges and strengths of Amgen

Interview with Miklós Auerbach, CEO of Gedeon Richter

An initiative of Kern Pharma. Closed the 7th edition of the Own Title of University Expert in Biosimilars

Montse Planas: "The health system has to invent measures that promote the use of biosimilars"

"Spain has the opportunity to be a benchmark for Europe in biosimilars"

Kern Pharma wins SABER Awards EMEA for its Biosimilar Hunters app

View of the Minister of Science and Innovation, Pedro Duque, at the mAbxience biosimilar manufacturing plant.

Biosimilars: for value-based healthcare

Insud Pharma has 3 plants in the province of León that generate more than 600 jobs

Fresenius Kabi highly values its entry into the field of biosimilars, on the first anniversary of the launch of Idacio

Kern Pharma donates 200 computers to support the training of young people during the 2020/2021 academic year

Fresenius Kabi donates more than 110.000 masks and gloves during the coronavirus crisis to help healthcare professionals in Spain

Amgen and Adaptative Biotechnologies to develop a treatment for the coronavirus

Novartis plans to publish hydroxychloroquine data this month

Pfizer advances with its projects to contribute to the treatment and prevention of Covid-19

Sanofi includes Spain among the countries that will receive its medicine against the coronavirus

Coronavirus.- STADA donates 50.000 masks and hygiene products to fight Covid-19

Novartis donates critical material for hospitals worth one million euros to the health air corridor

Rovi announces the donation of one million masks to Health

mAbxience inaugurates a new biosimilar monoclonal antibody plant in Argentina

Kern Pharma launches “Biosimilar Hunters”, the first app on biosimilars

ABOUT BIOSIM

ABOUT BIOSIMILARS

BioSim Newsletter